FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
Dockets Management


Volume 1

Reference List

Reference 1 - National Institutes of Health (NM) (2004). Consensus statement on celiac disease, June 28-30. Accessible on June 2005 at http://consensus.nih.gov/cons/118/118celiacPDF.pdf

Reference 2 - Kasarda, D. D. (2001). Grains in relation to celiac disease. CerealFoods World, 46(5):209-10. Published Material

Reference 3 - Janatuinen, E. K., Kemppainen, T. A., Julkunen, R. J., Kosma, V. M., Maki, M., Heikkinen,M., Uusitupa, M. I. (2002). No harm from five year ingestion of oats in coeliac disease. Gut, 50(3): 332-335. Published Material

Reference 4 - Janatuinen, E. K., Kemppainen, T. A., Pikkarainen, P. H., Holm, K. H., Kosma, V.M., Uusitupa, M.I., Maki, M., Julkunen, R. J. (2000). Lack of cellular and humoral immunological responses to oats in adults with coeliac disease, Gut, 46(3): 327-331. Published Material

Reference 5 - Janatuinen, E. K., Pikkarainen, P. H., Kemppainen, T. A., Kosma, V. M., Jarvinen, R. M., Uusitupa, M. I., Julkunen, R. J. (1995). A Comparison of Diets with and without Oats in Adults with Celiac Disease. N Eng J Med, 333(16): 1033-1037. Published Material

Reference 6 - Lundin, K. E., Nilsen, EM., Scott, H.G., Loberg, E. M., Gjoen, A., Bratlie, J., Skar, V., Mendez, E., Lovik, A., Kett, K. (2003). Oats induced viflous atrophy in coeliac disease. Gut, 52(11): 1649-1652. Published Material

Reference 7 - Arentz-Hansen, H., Fleckenstein, B., Molberg, O., Scott, H., Koning, F., Jung, G., Roepstorff: P., Lundin, K. E., Sollid, L. M, (2004). The molecular basis for oat intolerance in patients with celiac disease. Plos Med, 1: 84-92. Published Material

Reference 8 - Thompson, T. (2004), Gluten contamination of commercial oat products in the United States.N Engl J Med, 351(19): 2021-2022. Published Material

Reference 9 - Brown A. (2004) Understanding Food Principles and Preparation, Second Edition. Wadsworth/Thomson Learning, Belmont CA, USA, p. 402-403. Published Material

Reference 10 - Corrao, G., Corazza, G. R., Bagnardi, V., Brusco, G., Ciacci, C., Cottone, M., Sategna Guidetti, C., Usai, P., Cesari, P., Pelli, M. A., Loperfido, S., Volta, U., Calabro, A., Certo, M. (2001). Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet, 358: 356-361. Published Material

Reference 11 - Dewar, D., Pereira, S. P., Ciclitira, P. J. (2004). The pathogenesis of coeliac disease. Int J Biochem Cell Biol, 36: 17-24. Published Material

Reference 12 - Fasano, A. and Catassi, C. (2001). Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum, Gastroenterology, 120(3): 636-651. Published Material

Top | Back

Page last updated August 12, 2005 RSChorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management